Caplin Point Laboratories Signs ₹925 Crore MoU to Establish Four New Manufacturing Units in Tamil Nadu
Caplin Point Laboratories Ltd has signed a Memorandum of Understanding (MoU) committing an investment of ₹925 crore to establish four new state-of-the-art pharmaceutical manufacturing...
New Genomic Study Reveals Origin of DRC’s Ebola Outbreak
A new genomic analysis published in Nature Medicine has identified the cause of the Ebola outbreak sweeping the Democratic Republic of the Congo (DRC):...
Blue Jet Healthcare Inaugurates Advanced R&D Centre in Hyderabad to Accelerate Green Chemistry and Pharmaceutical Innovation
Blue Jet Healthcare Ltd, a prominent global contract development and manufacturing organization (CDMO), has officially inaugurated its state-of-the-art Research and Development (R&D) Centre in...
Shukra Pharmaceuticals Expands into MedTech Following Landmark NSE Listing
Shukra Pharmaceuticals has officially marked a major milestone in its corporate growth journey with its new listing on the National Stock Exchange (NSE). The listing...
CCRAS-NIIMH & Kerala’s SEMIRI Join Hands to Digitise Rare Ayurvedic Manuscripts
The National Institute of Indian Medical Heritage (NIIMH), operating under the Central Council for Research in Ayurvedic Sciences (CCRAS) within the Ministry of Ayush, has signed a...
New Hope in Multiple Myeloma Treatment as FDA Approves Zenbexus-Based Regimen
The U.S. Food and Drug Administration has granted accelerated approval to Zenbexus(iberdomide), Bristol Myers Squibb's oral cereblon-modulating protein degrader, for use alongside daratumumab and hyaluronidase-fihj and dexamethasone in adults with...
